Burn News and Research

RSS

Thrombogenics issues business update and half year results

ThromboGenics NV (Euronext Brussels: THR), a biotechnology company focused on the discovery and development of innovative treatments for eye disease, vascular disease and cancer, is today issuing a business update and its half year results for the six month period ending 30 June, 2009.

28 Aug 2009

Urodynamix Technologies announces fiscal 2009 second-quarter financials

Urodynamix Technologies Ltd. (TSX VENTURE:URO) today reported its financial results for its fiscal second quarter ended June 30, 2009. The Company reported revenues of $21,871, a 70% decrease over the same quarter of the prior year. The Company's order backlog at June 30, 2009 was $92,576 compared to nil at the end of the comparative quarter June 30, 2008.

28 Aug 2009

Medical journal article highlights the challenges faced by healthcare providers for treating patients with non-healing wounds

Cardium Therapeutics today reported that a recent medical journal article highlights the challenges facing healthcare providers with respect to finding optimal treatments for patients with non-healing wounds.

28 Aug 2009

Fatostatin lowers the activity of genes associated with cholesterol synthesis

A small molecule earlier found to have both anti-fat and anti-cancer abilities works as a literal turnoff for fat-making genes, according to a new report in the August 28th issue of the journal Chemistry and Biology, a Cell Press journal.

27 Aug 2009

Stemedica unveils two of its latest scientific discoveries at the 2009 World Stem Cell Summit

Stemedica Cell Technologies , Inc., ("Stemedica"), a world leader in stem cell research and manufacturing (a licensed manufacturer of clinical grade biological products as licensed by the State of California Food and Drug Branch) continues to advance the stem cell industry with the presentation of two of its latest scientific discoveries at the 2009 World Stem Cell Summit.

27 Aug 2009

MedAssets to deliver transformational revenue cycle solutions for Saint Barnabas Health Care System

MedAssets, Inc. today announced that it has signed a long-term agreement to deliver its transformational revenue cycle solutions to Saint Barnabas Health Care System (SBHCS), the largest integrated health care delivery system in New Jersey. MedAssets will provide revenue cycle process reengineering services, powered by the continued deployment of web-based software and execution of ongoing primary accounts receivable billing and follow-up services.

26 Aug 2009

Defentect's radiation detection system to be installed at Washington Hospital Center

Defentect announced today Washington Hospital Center is deploying Defentect's radiation detection system hospital-wide following a pilot project to test its effectiveness, with an additional nine GT2(TM) radiation sensors and two GT4(TM) Gamma Radiation sensors, capable of isotopic identification.

26 Aug 2009

Study reveals safety of ConvaTec's advanced antimicrobial dressing

ConvaTec, a world-leading provider of innovative medical technologies for community and hospital care, today announced new data showing that AQUACEL(R) Ag, the company's advanced antimicrobial dressing, is safe for use in an MRI environment.

25 Aug 2009

Celsius Holdings introduces calorie burning beverage in New York and Pennsylvania

Celsius Holdings, Inc. (OTCBB: CSUH) announced today that Celsius®, the original calorie burning beverage, is now available at all 76 Tops Friendly Markets locations in New York and Pennsylvania.

25 Aug 2009

Neurogen stockholders to receive $11 million in Ligand Pharmaceuticals common stock as part of acquisition deal

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) and Neurogen Corporation (NASDAQ:NRGN) announced today they have entered into a definitive merger agreement under which Ligand will acquire Neurogen. Under the transaction, Neurogen stockholders will receive an estimated $11 million in Ligand common stock and will be granted Contingent Value Rights (“CVRs”) under four CVR agreements.

25 Aug 2009

American Council on Exercise reveals fitness and nutrition tips for students

As students all across the country flock to college campuses this month, The American Council on Exercise (ACE), America's leading authority on fitness and one of the largest fitness certification, education and training organizations in the world, today revealed its top ten fitness and nutrition tips for remaining in good health for the 2009 school year.

22 Aug 2009

Coping with burn injuries

More than half a million Americans are treated for burn injuries every year, but many do not have the specific skills necessary to cope with the experience of living with a burn injury after they leave the hospital.

20 Aug 2009

DNA-encased carbon nanotubes used for treating human prostate cancer tumors in mice

Researchers at Wake Forest University School of Medicine have destroyed prostate cancer tumors in mice by injecting them with specially-coated, miniscule carbon tubes and then superheating the tubes with a brief zap of a laser.

20 Aug 2009

Arpida reports financials for the six months ending 30 June 2009

CFO Harry Welten, MBA, commented: "Our cost-saving measures have been implemented, resulting in a substantial reduction of the cash burn. We expect to have cash and financial investments of around CHF 14 million at the end of 2009."

19 Aug 2009

Researchers find connection between eye disease and arginase

Elevated levels of the enzyme arginase contribute to vascular eye damage and Medical College of Georgia researchers say therapies to normalize its levels could halt progression of potentially blinding diseases such as diabetic retinopathy.

19 Aug 2009

Novavax reports positive preclinical results for H1N1 influenza VLP vaccine

Novavax, Inc. (Nasdaq: NVAX) announced positive preclinical results with Novavax's 2009 novel H1N1 influenza virus-like particle (VLP) vaccine. The study, conducted by scientists from Novavax and the Centers for Disease Control and Prevention (CDC) based in Atlanta, GA, under a collaborative agreement, represents the first efficacy report of a 2009 novel H1N1 vaccine in ferrets. The ferret model is widely accepted to be the most appropriate animal model for evaluating influenza disease and vaccines. Novavax scientists designed the vaccine using recombinant virus like particles (VLP) technology against an H1N1 virus strain (A/California/04/2009) isolated in the beginning of the 2009 H1N1 outbreak.

19 Aug 2009

FDA approves Helixate FS for routine prophylaxis in children with hemophilia A

CSL Behring announced today that Helixate® FS, Antihemophilic Factor (Recombinant), has been approved by the U.S. Food and Drug Administration (FDA) for routine prophylaxis in children with hemophilia A who are 16 years old or younger and do not have pre-existing joint damage.

17 Aug 2009

Possible neurological complications of heart surgery detailed in new report

In the most comprehensive and up-to-date review of its kind, researchers list possible nervous system complications of bypass surgeries, aortic surgery, cardiac catheterizations, valve replacements, heart transplants and surgeries for congenital heart disease and heart tumors.

13 Aug 2009

Neurological complications of heart surgery detailed in research

Possible neurological complications of heart surgery, ranging from headaches to strokes, are detailed in a new report in the online journal MedLink Neurology.

13 Aug 2009

Innovative projects addressing childhood obesity

Youth Service America (YSA) and UnitedHealth Group team up for the second year to offer UnitedHealth HEROES grants to youth-led service-learning projects addressing childhood obesity.

10 Aug 2009

Burn News and Research

Thrombogenics issues business update and half year results

Urodynamix Technologies announces fiscal 2009 second-quarter financials

Medical journal article highlights the challenges faced by healthcare providers for treating patients with non-healing wounds

Fatostatin lowers the activity of genes associated with cholesterol synthesis

Stemedica unveils two of its latest scientific discoveries at the 2009 World Stem Cell Summit

MedAssets to deliver transformational revenue cycle solutions for Saint Barnabas Health Care System

Defentect's radiation detection system to be installed at Washington Hospital Center

Study reveals safety of ConvaTec's advanced antimicrobial dressing

Celsius Holdings introduces calorie burning beverage in New York and Pennsylvania

Neurogen stockholders to receive $11 million in Ligand Pharmaceuticals common stock as part of acquisition deal

American Council on Exercise reveals fitness and nutrition tips for students

Coping with burn injuries

DNA-encased carbon nanotubes used for treating human prostate cancer tumors in mice

Arpida reports financials for the six months ending 30 June 2009

Researchers find connection between eye disease and arginase

Novavax reports positive preclinical results for H1N1 influenza VLP vaccine

FDA approves Helixate FS for routine prophylaxis in children with hemophilia A

Possible neurological complications of heart surgery detailed in new report

Neurological complications of heart surgery detailed in research

Innovative projects addressing childhood obesity

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News